Zobrazeno 1 - 10
of 15
pro vyhledávání: '"C. C. Gispen-de Wied"'
Autor:
C. C. Gispen-de Wied, Marieke Biegstraaten, Carla E. M. Hollak, Yvonne Schuller, Violeta Stoyanova-Beninska
Publikováno v:
Drugs
Drugs, 77(13), 1461-1472. Adis International Ltd
Drugs, 77(13), 1461-1472. Adis International Ltd
Introduction Authorization of orphan medicinal products (OMPs) is often based on studies with several methodological shortcomings. Hence, data are difficult to interpret and efficacy does not always correspond to real-world effectiveness. We investig
Autor:
G. J. M. W. van Thiel, C. C. Gispen-de Wied, J.J.M. van Delden, Nancy S. Breekveldt, Rosemarie D. L. C. Bernabe
Publikováno v:
Current Medical Research and Opinion, 35(4), 637. Informa Healthcare
Background: Within the EU, regulators are obliged to take ethical issues into consideration during marketing authorization deliberation. The goal of this manuscript is to identify what kinds of ethical issues regulators encounter during marketing aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec42513f73c1822ac768e5c22dcff3e
https://dspace.library.uu.nl/handle/1874/381166
https://dspace.library.uu.nl/handle/1874/381166
Autor:
C C M, Welten, M W J, Koeter, T, Wohlfarth, J G, Storosum, W, van den Brink, C C, Gispen-de Wied, H G M, Leufkens, D A J P, Denys
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 25(7)
We examined the role of placebo response in acute mania trials. Specifically, whether placebo response: (1) predicts treatment effect, (2) can be predicted by patient and study characteristics, and (3) can be predicted by a parsimonious model. We per
Autor:
C. C. Gispen-de Wied, Chantal Kemner, Herman Westenberg, René S. Kahn, Bob Oranje, Marinus N. Verbaten
Publikováno v:
Journal of Psychopharmacology. 18:388-394
Schizophrenic patients show a loss of sensory gating, which is reflected in a reduced P50 suppression. Because most of the symptoms inschizophrenia can be reduced by antagonists of the dopaminergic (D2) system, the loss in sensory gating might be rel
Publikováno v:
Clinical Chemistry. 42:1238-1242
We conducted experiments to demonstrate that the determination of dexamethasone in saliva is a valuable tool to assess dexamethasone concentrations in the body after administration of this synthetic corticosteroid. After extraction of saliva, a RIA i
Publikováno v:
The journal of nutrition, healthaging. 13(4)
To evaluate the validity of biomarkers that are currently being proposed as potential surrogate endpoints in AD clinical trials with the aid of the "Quantitative Surrogate Validation Level of Evidence Schema" (QSVLES) proposed by Lassere et.al. (1).A
Autor:
Herman Westenberg, René S. Kahn, Marinus N. Verbaten, Chantal Kemner, Bob Oranje, C. C. Gispen-de Wied
Publikováno v:
Journal of psychopharmacology (Oxford, England). 20(6)
Patients with schizophrenia exhibit diverse cognitive deficits, one of which is a loss of the ability to focus attention. According to the revised dopamine hypothesis of schizophrenia both an increased mesolimbic and a decreased prefrontal dopaminerg
Autor:
D, Cohen, C C, Gispen-de Wied
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 147(21)
Three male schizophrenia patients, aged 41, 40 and 61 years respectively, who had undergone treatment without a satisfactory result, were treated with the antipsychotic clozapine. Diabetes mellitus developed within a period of several months to sever
Publikováno v:
Clinical chemistry. 42(8 Pt 1)
We conducted experiments to demonstrate that the determination of dexamethasone in saliva is a valuable tool to assess dexamethasone concentrations in the body after administration of this synthetic corticosteroid. After extraction of saliva, a RIA i
Publikováno v:
Clinical Pharmacology & Therapeutics. 83:812-812